Biomea Fusion, Inc. (BMEA) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 66 transactions totaling $69.1M, demonstrating a bullish sentiment with $3.5M in net insider flow. The most recent transaction on Dec 11, 2025 involved a purchase of 30,000 shares valued at $42.9K.
No significant insider buying has been recorded for BMEA in the recent period.
No significant insider selling has been recorded for BMEA in the recent period.
Based on recent SEC filings, insider sentiment for BMEA is bullish with an Insider Alignment Score of 53/100 and a net flow of $3.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Biomea Fusion, Inc. (BMEA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading BMEA stock, having executed 66 transactions in the past 90 days. The most active insider is Pharmaceuticals, Inc. A2a (Executive), who has made 12 transactions totaling $33.6M.
Get notified when executives and directors at BMEA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | M. Erdtmann Rainer | Executive | Purchase | 30,000 | $1.43 | $42.9K | |
| Dec 2, 2025 | J.m. Hitchcock Michael | Executive | Purchase | 100,000 | $0.99 | $99.0K | |
| Dec 1, 2025 | M. Erdtmann Rainer | Executive | Purchase | 10,000 | $1.05 | $10.5K | |
| Nov 28, 2025 | M. Erdtmann Rainer | Executive | Purchase | 40,000 | $1.10 | $44.0K | |
| Jan 31, 2025 | M. Erdtmann Rainer | Executive | Gift | 10,000 | $N/A | $0 | |
| Jan 31, 2025 | M. Erdtmann Rainer | Executive | Gift | 10,000 | $N/A | $0 | |
| Jan 31, 2025 | M. Erdtmann Rainer | Executive | Gift | 10,000 | $N/A | $0 | |
| Jan 31, 2025 | M. Erdtmann Rainer | Executive | Gift | 10,000 | $N/A | $0 | |
| Jan 31, 2025 | M. Erdtmann Rainer | Executive | Gift | 10,000 | $N/A | $0 | |
| Jan 31, 2025 | M. Erdtmann Rainer | Executive | Gift | 10,000 | $N/A | $0 | |
| Jan 28, 2025 | M. Erdtmann Rainer | Executive | Gift | 40,000 | $N/A | $0 | |
| Jun 11, 2024 | Valle Franco | Executive | Purchase | 12,509 | $4.43 | $55.4K | |
| May 31, 2024 | Pablo Frias Juan | Executive | Award | 349 | $8.94 | $3.1K | |
| May 31, 2024 | Valle Franco | Executive | Award | 4,448 | $3.78 | $16.8K | |
| Dec 29, 2023 | M. Erdtmann Rainer | Executive | Gift | 3,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 24 | $36.3M | 52.5% |
Sale(S) | 10 | $32.8M | 47.4% |
Award(A) | 6 | $66.1K | 0.1% |
Gift(G) | 24 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Conversion(C) | 1 | $0 | 0.0% |
Insider activity at Biomea Fusion, Inc. shows mixed signals across all time. While $36.3M in purchases indicates some executive confidence,$32.8M in sales balances the picture, resulting in a modest net flow of $3.5M.10 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Pharmaceuticals, Inc. A2a, has transacted $33.6M during this period.